ACOT11 Enzyme as A Potential Drug Target and Biomarker for Various Diseases

Target Name: ACOT11

NCBI ID: G26027

ACOT11

ACOT11 Enzyme as A Potential Drug Target and Biomarker for Various Diseases

Acetyl-CoA Transferase 11 (ACOT11) is a protein that is expressed in various tissues throughout the body. It is a key enzyme in the citric acid cycle, also known as the Krebs cycle or tricarboxylic acid (TCA) cycle, which is a central metabolic pathway that generates energy in the form of ATP from food molecules. The ACOT11 gene has been identified and is localized to the X chromosome.

The ACOT11 protein plays a crucial role in the regulation of cellular energy metabolism. It is involved in the transfer of acetyl groups from the electron-carrying A-subunits of coenzyme A to the carbonyl group of CoA, which is the final step in the citric acid cycle. The ACOT11 enzyme is highly conserved across various species, and it has been shown to be involved in a wide range of physiological processes, including cell growth, differentiation, and metabolism.

Drug Targets and Biomarkers

The ACOT11 gene has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. The ACOT11 enzyme has been shown to be involved in the regulation of cellular processes that are disrupted in these diseases, including the production of reactive oxygen species (ROS), which can cause damage to cellular components and contribute to the development of diseases.

One of the potential benefits of targeting ACOT11 is its potential to inhibit the production of ROS, which has been shown to play a role in the development of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. The ACOT11 enzyme has been shown to be involved in the production of ROS, and inhibitors have been shown to be effective in reducing ROS production in cell culture models of these diseases.

Another potential benefit of targeting ACOT11 is its potential to serve as a biomarker for the diagnosis and progression of these diseases. The ACOT11 gene has been shown to be expressed in a wide range of tissues and has been used as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

Expression and Function

The ACOT11 gene is expressed in a variety of tissues throughout the body, including muscle, heart, brain, and cancer cells. It is primarily expressed in the cytoplasm and is shown to be involved in the production of various cellular components, including mitochondrial proteins and cytoskeletal components.

The ACOT11 enzyme is a key component of the citric acid cycle and is involved in the transfer of acetyl groups from the electron-carrying A-subunits of coenzyme A to the carbonyl group of CoA. The ACOT11 enzyme is highly conserved across various species and has have been shown to have similar catalytic properties to the human ACOT11 enzyme.

The ACOT11 enzyme has been shown to play a role in a wide range of physiological processes, including cell growth, differentiation, and metabolism. It has been shown to be involved in the regulation of cellular energy metabolism, including the production of ATP and the metabolism of fatty acids. The ACOT11 enzyme is also involved in the regulation of cellular signaling pathways, including the production of reactive oxygen species (ROS) and the regulation of ion channels.

The ACOT11 gene has been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. The ACOT11 enzyme has been shown to be involved in the production of ROS, which can contribute to the development of these diseases.

Conclusion

In conclusion, ACOT11 is a protein that is expressed in various tissues throughout the body and plays a crucial role in the regulation of cellular energy metabolism. The ACOT11 enzyme is involved in the transfer of acetyl groups from the electron-carrying A-subunits of

Protein Name: Acyl-CoA Thioesterase 11

Functions: Has an acyl-CoA thioesterase activity with a preference for the long chain fatty acyl-CoA thioesters hexadecanoyl-CoA/palmitoyl-CoA and tetradecanoyl-CoA/myristoyl-CoA which are the main substrates in the mitochondrial beta-oxidation pathway

The "ACOT11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ACOT11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets